Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Renal Insufficiency × melflufen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Renal Insufficiency 1

Interventions

Dexamethasone 10 Bortezomib 7 Lenalidomide 4 isatuximab 3 Calcium Dobesilate 3 pomalidomide 2 Thalidomide 2 Gemcitabine 2 Cyclophosphamide 2 vinflunine 1 melflufen 1 gallium 68 PSMA-11 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 carfilzomib 1 auricularum 1 Tablets 1 Ranitidine 1 Pluvicto 1 L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1 Eplerenone 1 Doxorubicin 1 Diphenhydramine 1 Carboplatin 1 Bendamustine Hydrochloride 1 BHQ880 1 Acetaminophen 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03639610 2023-03-10

BRIDGE

Oncopeptides AB

Phase 2 Terminated

35 enrolled 33 charts

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡